Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
- PMID: 33487197
- PMCID: PMC7870908
- DOI: 10.1017/ice.2021.20
Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
Abstract
The sensitivity of the BinaxNOW coronavirus disease 2019 (COVID-19) Ag Card test (BinaxNOW) was 51.6% among asymptomatic healthcare employees relative to real-time reverse transcriptase polymerase chain reaction (rRT-PCR). The odds of a positive BinaxNOW test decreased as cycle threshold value increased. BinaxNOW could facilitate rapid detection and isolation of asymptomatically infected persons in some settings while rRT-PCR results are pending.
Figures
References
-
- BinaxNOW COVID-19 Ag Card—Letter of Authorization, August 26, 2020. US Food & Drug Administration website. https://www.fda.gov/media/141567/download. Published 2020. Accessed January 2021.
-
- Abbott BinaxNOW COVID-19 test fact sheet. US Department of Health & Human Services (HHS) website. https://www.hhs.gov/sites/default/files/abbott-binaxnow-fact-sheet.pdf. Published 2020. Accessed January 2021.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous